Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

SKYRIZI 180 MG SOLUCION INYECTABLE EN CARTUCHO - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/SKYRIZI 180 MG SOLUCION INYECTABLE EN CARTUCHO

Approved

STANDARD

SKYRIZI 180 MG SOLUCION INYECTABLE EN CARTUCHO

Abbvie Deutschland Gmbh & Co. Kg🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Aug 1, 2024
Approval ID: b9f026197f6e3232
Company: Abbvie Deutschland Gmbh & Co. Kg
Type: Standard

Approval Details

Approval Id: b9f026197f6e3232
Drug Cima Aemps Name: SKYRIZI 180 MG SOLUCION INYECTABLE EN CARTUCHO
Register Number: 1191361007
Holder Company Name: Abbvie Deutschland Gmbh & Co. Kg
Marketing Company Name: Abbvie Spain, S.L.U.
Holder Company Detail Path: /organization/abbvie-deutschland-gmbh-and-co-kg
Authorization Date: 2024-08-01
Dosage Form: SOLUCIÓN INYECTABLE EN CARTUCHO
Dose: 180 mg
Route Of Administration: VÍA SUBCUTÁNEA
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Abbvie Deutschland Gmbh & Co. Kg
Company Detail Path: /organization/abbvie-deutschland-gmbh-and-co-kg

Company Information

Pharmaceutical Company Name: AbbVie Deutschland GmbH & Co. KG
Country Name: Germany
City Name: ludwigshafen am rhein,rheinland-pfalz,country_de
Address: Knollstr. 50
Website: http://www.abbvie.de

Active Ingredients

RISANKIZUMAB

180 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Aug 1, 2024

Approval ID

b9f026197f6e3232

Type

Standard

Back to CIMA-AEMPS Approvals